-
1.Substituted benzamidine compounds which have useful pharmaceutical activity 失效
标题翻译: 具有有用药物活性的取代苄脒化合物公开(公告)号:US5731332A
公开(公告)日:1998-03-24
申请号:US765692
申请日:1997-03-28
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Armin Fugner , Hubert Heuer , Christopher Meade
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Armin Fugner , Hubert Heuer , Christopher Meade
IPC分类号: C07D213/81 , A61K31/00 , A61K31/155 , A61K31/165 , A61K31/27 , A61K31/44 , A61K31/4406 , A61K31/4409 , A61P1/00 , A61P5/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P17/00 , A61P25/04 , A61P25/28 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/08 , A61P43/00 , C07C257/18 , C07C257/20 , C07C259/18 , C07C269/06 , C07C271/64
CPC分类号: C07C271/64
摘要: Compounds of formula ##STR1## and their therapeutic use, inter alia, as LTB.sub.4 -antagonists. Exemplary compounds are: (Methoxycarbonyl-imino-{4'-�2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-methyl)-amine; (Benzyloxycarbonyl-imino-{4'-�2-(2-propylphenoxy)-ethoxy!-biphenyl-4-yl}-methyl-amine; �Hydroxy-imino-(4-{3-�4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzoyloxy}phenyl)-methyl!-amine; �Ethoxycarbonyl-imino-(4-{3-�4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzoyloxy}phenyl)-methyl!-amine; and, �3'-Pyridylcarbonyl-imino-(4-{3-�4-(1-methyl-1-phenylethyl)-phenoxymethyl!-benzyloxy}phenyl)-methyl!-amine.
摘要翻译: PCT No.PCT / EP95 / 02112 Sec。 371日期:1996年3月28日 102(e)1996年3月28日PCT提交1995年6月3日PCT公布。 公开号WO96 / 02497 日期1996年2月1日公式(IMAGE)(I)的化合物及其治疗用途,特别是作为LTB4拮抗剂。 示例性化合物是:(甲氧基羰基 - 亚氨基 - {4' - [2-(2-丙基苯氧基) - 乙氧基] - 联苯-4-基} - 甲基} (苄氧基羰基 - 亚氨基 - {4' - [2-(2-丙基苯氧基) - 乙氧基] - 联苯-4-基} - 甲胺; [羟基亚氨基 - (4- {3- [4- 苯乙基) - 苯氧基甲基] - 苯甲酰氧基}苯基) - 甲基] - 胺; [乙氧基羰基 - 亚氨基 - (4- {3- [4-(1-甲基-1-苯乙基) - 苯氧基甲基] - 苯甲酰氧基}苯基) - 甲基] - 胺;和[3'-吡啶基羰基 - 亚氨基 - (4- {3- [4-(1-甲基-1-苯基乙基) - 苯氧基甲基] - 苄氧基}苯基) - 甲基] - 胺。
-
2.Chemical compound, the preparation thereof and its use in pharmaceutical compositions 失效
标题翻译: 化合物,其制备方法及其在药物组合物中的应用公开(公告)号:US5686496A
公开(公告)日:1997-11-11
申请号:US765527
申请日:1997-03-28
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Armin Fugner , Hubert Heuer , Christopher Meade
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Armin Fugner , Hubert Heuer , Christopher Meade
IPC分类号: A61K31/155 , A61P1/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P17/00 , A61P25/28 , A61P29/00 , A61P35/00 , A61P37/08 , A61P43/00 , C07C257/18
CPC分类号: C07C257/18 , Y10S514/825 , Y10S514/826 , Y10S514/863 , Y10S514/903 , Y10S514/908
摘要: The new compound of formula ##STR1## may be prepared by conventional methods and used therapeutically as an LTB.sub.4 -receptor antagonist.
摘要翻译: PCT No.PCT / EP95 / 02113 Sec。 371日期1997年3月28日 102(e)日期1997年3月28日PCT Filed June 3,1995 PCT Pub。 公开号WO96 / 02496 日期1996年2月1日新化合物式(Ⅰ)可以用常规方法制备,并用作治疗性的LTB4受体拮抗剂。
-
3.Amidine derivatives, the preparation and use thereof as medicaments with Itb4 antagonistic effect 有权
标题翻译: 脒衍生物,其制备和用途为具有Itb4拮抗作用的药物公开(公告)号:US06489365B1
公开(公告)日:2002-12-03
申请号:US09484073
申请日:2000-01-18
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Frank Himmelsbach , Franz Birke , Armin Fugner
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Frank Himmelsbach , Franz Birke , Armin Fugner
IPC分类号: A61K3124
CPC分类号: C07D213/78 , C07C257/18 , C07C317/18 , C07C317/22 , C07C317/44 , C07C323/20 , C07C323/62 , C07D307/79 , C07D311/22
摘要: Compounds of the formula which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
摘要翻译: 在说明书中更全面地解释的制剂的化合物可以通过常规方法制备并在常规的盖伦制剂中治疗地使用。
-
4.
公开(公告)号:US6037377A
公开(公告)日:2000-03-14
申请号:US460961
申请日:1995-06-05
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Frank Himmelsbach , Franz Birke , Armin Fugner
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Frank Himmelsbach , Franz Birke , Armin Fugner
IPC分类号: C07C257/18 , A61K31/155 , A61K31/34 , A61K31/343 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/40 , A61K31/415 , A61K31/42 , A61K31/421 , A61K31/44 , A61P1/04 , A61P11/00 , A61P11/06 , A61P17/06 , A61P29/00 , A61P37/08 , C07C303/40 , C07C311/29 , C07C315/04 , C07C317/18 , C07C317/22 , C07C317/44 , C07C319/20 , C07C323/18 , C07C323/20 , C07C323/32 , C07C323/62 , C07D213/78 , C07D231/00 , C07D263/32 , C07D277/00 , C07D307/78 , C07D307/79 , C07D311/22 , C07D317/66 , C07D319/18 , C07D333/00 , C07D333/38
CPC分类号: C07D213/78 , C07C257/18 , C07C317/18 , C07C317/22 , C07C317/44 , C07C323/20 , C07C323/62 , C07D307/79 , C07D311/22
摘要: Compounds of the formula ##STR1## which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
-
5.Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect 有权
标题翻译: 苄脒衍生物及其作为具有LTB4拮抗作用的药物的用途公开(公告)号:US06265612B1
公开(公告)日:2001-07-24
申请号:US09728856
申请日:2000-12-01
申请人: Kurt Schromm , Ralf Anderskewitz , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade
发明人: Kurt Schromm , Ralf Anderskewitz , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade
IPC分类号: C07C25718
CPC分类号: C07D295/088 , C07C257/18 , C07C271/64
摘要: The present invention relates to new benzamidine derivatives, processes for preparing them and their use in pharmaceutical compositions. The new benzamidine derivatives correspond to general formula 1
摘要翻译: 本发明涉及新的苄脒衍生物,其制备方法及其在药物组合物中的用途。 新的苯甲脒衍生物对应于通式1
-
6.Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments 有权
标题翻译: 苄胺和苯乙胺衍生物,其制备方法及其作为药物的用途公开(公告)号:US06288277B1
公开(公告)日:2001-09-11
申请号:US09423160
申请日:2000-04-03
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade
IPC分类号: C07C21100
CPC分类号: C07D295/192 , C07C217/58 , C07C217/60 , C07C271/16 , C07C317/22 , C07C323/20 , C07C2601/04
摘要: The present invention relates to new phenylamine derivatives, processes for preparing them and their use as pharmaceutical compositions. The phenylamines according to the invention correspond to the general formula I
摘要翻译: 本发明涉及新的苯胺衍生物,其制备方法及其作为药物组合物的用途。 根据本发明的苯胺对应于通式I
-
7.Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect 有权
标题翻译: 苄脒衍生物及其作为具有LTB4拮抗作用的药物的用途公开(公告)号:US06197824B1
公开(公告)日:2001-03-06
申请号:US09242389
申请日:2000-06-02
申请人: Kurt Schromm , Ralf Anderskewitz , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade
发明人: Kurt Schromm , Ralf Anderskewitz , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade
IPC分类号: A61K31155
CPC分类号: C07D295/088 , C07C257/18 , C07C271/64
摘要: Novel benzamidines, having LTB4-antagonistic activity, of the formula methods for their preparation, their and their use as medicaments.
摘要翻译: 具有LTB4拮抗活性的新型苯甲脒,其制备方法及其作为药物的用途。
-
公开(公告)号:US06197753B1
公开(公告)日:2001-03-06
申请号:US09264649
申请日:1999-03-08
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Hans M. Jennewein , Christopher J. M. Meade , Andreas Ding
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Hans M. Jennewein , Christopher J. M. Meade , Andreas Ding
IPC分类号: A61K3170
CPC分类号: C07H15/203 , A61K31/70
摘要: Pyranoside derivatives of the formula I wherein 1, m and n independently of one another denote an integer chosen from 0, 1, 2, 3 and 4 and 1+m+n≦4. These are are LTB4-antagonists. Also disclosed are processes for making these compounds.
摘要翻译: 式I中的吡喃糖苷衍生物,其中m和n彼此独立地表示选自0,1,2,3和4以及1 + m + n <= 4的整数。 这些是LTB4拮抗剂。 还公开了制备这些化合物的方法。
-
9.Phenylamidine derivatives, a process for preparing the same and their use as medicaments 失效
标题翻译: 苯脒衍生物,其制备方法及其作为药物的用途公开(公告)号:US6127423A
公开(公告)日:2000-10-03
申请号:US77900
申请日:1998-07-31
申请人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade , Andreas Ding
发明人: Ralf Anderskewitz , Kurt Schromm , Ernst-Otto Renth , Franz Birke , Hans Michael Jennewein , Christopher John Montague Meade , Andreas Ding
IPC分类号: C07D295/18 , A61K31/00 , A61K31/155 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/445 , A61K31/4453 , A61P1/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/00 , A61P19/02 , A61P25/28 , A61P37/00 , C07C257/18 , C07C275/24 , C07C311/08 , C07C311/21 , C07D211/06 , C07D295/185
CPC分类号: C07D295/185 , C07C257/18 , C07C275/24 , C07C311/08 , C07C311/21 , C07C2101/08 , C07C2101/14 , Y10S514/825 , Y10S514/826 , Y10S514/863 , Y10S514/903 , Y10S514/908
摘要: The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions. The phenylamidines according to the invention correspond to the general formula I ##STR1##
摘要翻译: PCT No.PCT / EP96 / 05529 Sec。 371日期:1998年7月31日 102(e)1998年7月31日PCT PCT 1996年12月11日PCT公布。 公开号WO97 / 21670 PCT 日期1996年6月19日本发明涉及新的苯基脒衍生物,其制备方法及其作为药物组合物的用途。 根据本发明的苯基脒对应于通式Ⅰ
-
公开(公告)号:US4581367A
公开(公告)日:1986-04-08
申请号:US443912
申请日:1982-11-23
申请人: Kurt Schromm , Anton Mentrup , Ernst-Otto Renth , Armin Fugner , Ilse Streller
发明人: Kurt Schromm , Anton Mentrup , Ernst-Otto Renth , Armin Fugner , Ilse Streller
IPC分类号: A61K31/41 , A61K31/415 , A61K31/4166 , A61K31/4184 , A61K31/42 , A61K31/496 , A61K31/505 , A61K31/517 , A61K31/535 , A61K31/5355 , A61P1/04 , A61P1/06 , A61P9/00 , A61P9/06 , A61P9/12 , A61P11/00 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/24 , A61P25/26 , A61P27/02 , A61P27/14 , A61P37/08 , C07D233/36 , C07D233/54 , C07D233/58 , C07D233/61 , C07D235/06 , C07D235/08 , C07D235/18 , C07D239/88 , C07D239/90 , C07D239/96 , C07D249/18 , C07D413/12 , C07D521/00 , C07D235/00
CPC分类号: C07D233/64 , C07D231/12 , C07D233/36 , C07D233/56 , C07D235/06 , C07D235/08 , C07D235/18 , C07D239/88 , C07D239/96 , C07D249/08 , C07D249/18 , Y10S514/821 , Y10S514/826 , Y10S514/849 , Y10S514/906 , Y10S514/914
摘要: Compounds of the formula whereinHet is a heterocycle;n is an integer from 1 to 4, inclusive, preferably 2 or 3;R.sub.1 is H or acyl;R.sub.2 is H, R.sub.1 O, --NHSO.sub.2 R.sub.7, --NHCOR.sub.8, --NHCONHR.sub.8, --NH--CH.sub.2 --C.sub.6 H.sub.4 --R.sub.9, --CH.sub.2 OH, --CH.sub.2 SO.sub.2 R.sub.7, --CONHR.sub.8, halogen or --CN;R.sub.3 is H, halogen, R.sub.7 or --OR.sub.7 ; orR.sub.2 and R.sub.3, together with each other, are ##STR1## N.sub.4 is H, --CH.sub.3 or --C.sub.2 H.sub.5 ; R.sub.5 and R.sub.6 are each H or --CH.sub.3 ;R.sub.7 is C.sub.1 -C.sub.4 alkyl;R.sub.8 is H or C.sub.1 -C.sub.4 alkyl; andR.sub.9 is H, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy optionally interrupted by oxygen;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as bronchospasmolytics, spasmolytics, muscle-relaxants, antiallergics and hypotensives.
摘要翻译: 其中Het是杂环的式“IMAGE”的化合物; n为1〜4的整数,优选为2或3; R1是H或酰基; R2是H,R1O,-NHSO2R7,-NHCOR8,-NHCONHR8,-NH-CH2-C6H4-R9,-CH2OH,-CH2SO2R7,-CONHR8,卤素或-CN; R3是H,卤素,R7或-OR7; 或R 2和R 3彼此一起是H,-CH 3或-C 2 H 5; R5和R6各自为H或-CH3; R7是C1-C4烷基; R8是H或C1-C4烷基; 并且R 9为H,任选被氧中断的C 1 -C 4烷基或C 1 -C 4烷氧基; 和无毒的,药学上可接受的酸加成盐。 化合物和盐可用作支气管解痉药,解痉药,肌肉松弛剂,抗过敏药和低血压药。
-
-
-
-
-
-
-
-
-